This hormone is produced in the gut and plays a key role in regulating blood sugar levels and controlling appetite
This strategy has been exploited in the long-acting GLP-1RA semaglutide (Novo Nordisk), for instance, which was approved for treatment of T2DM in 2017, and for treatment of obesity in 2021, and has since then become the most prescribed GLP-1RA 92
According to recently published clinical research by Galderma in January 2025, patients using GLP-1 medications frequently report significant facial alterations: Loss of facial volume creating shadowing and hollowness Increased skin laxity and sagging Changes in facial structure and balance Skin appearing less radiant and drier An overall aged appearance beyond their chronological age Dr
Week 1-3: You may experience mild digestive changes
If you want a proven weight loss medication right now, tirzepatide (Zepbound) and semaglutide (Wegovy) are FDA-approved, available by prescription, and produce meaningful results
The real value comes from medical oversight, clear pricing, personalized medication guidance, and a provider who stays involved after the first prescription
